1 – 11 of 11
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth
(
- Contribution to journal › Article
- 2023
-
Mark
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
(
- Contribution to journal › Article
- 2022
-
Mark
Inflammatory Animal Models of Parkinson's Disease
(
- Contribution to journal › Scientific review
-
Mark
APOE in the bullseye of neurodegenerative diseases : impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
(
- Contribution to journal › Scientific review
-
Mark
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
2022) In Acta Neuropathologica(
- Contribution to journal › Article
- 2020
-
Mark
Hyperinflammation and Fibrosis in Severe COVID-19 Patients : Galectin-3, a Target Molecule to Consider
(
- Contribution to journal › Article
-
Mark
The Ubiquitin Proteasome System in Neuromuscular Disorders : Moving Beyond Movement
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
(
- Contribution to journal › Article
- 2017
-
Mark
Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration
(
- Contribution to journal › Article
- 2015
-
Mark
Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation.
(
- Contribution to journal › Article
- 2014
-
Mark
The role of Galectin-3 in α-synuclein-induced microglial activation
(
- Contribution to journal › Scientific review